The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in
gene therapy, cell therapy and genetic vaccines by facilitating education, the exchange of
information and technology, and by serving as a professional adviser to stakeholder communities
and regulatory bodies in Europe.

Icon
UPDATE
 

ESGCT annual meeting in collaboration with DG-GT e.V.

Registration for the congress  and abstract submissions will open on May 2nd. Early bird and abstract
submission deadline is June 30th.
More information on the programme and practicalities are available
on the Berlin page.

Latest News

Feng Zhang Discusses CRISPR and Future of Gene Editing in Interview in Human Gene Therapy

Read more

New gene therapy success in a rare disease of the immune system: Wiskott-Aldrich syndrome

Read more

First stem-cell therapy recommended for approval in EU

Read more